KCNH2 and chronic obstructive pulmonary disease: These channels include the hERG K+ channel that is a target for many anti-arrhythmia drugs, as well as the KCNQ K+ channel, and mutations in both of these genes contribute to long QT syndrome (LQTS) which can trigger cardiac arrhythmias and are likely significant contributors to sudden cardiac death.